Patent details
EP2329821 Title: Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
Basic Information
- Publication number:
- EP2329821
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP101707982
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
- French Title of Invention:
- Traitement de troubles neovasculaires oculaires comme par example dègèneresence maculaire, uveite et oedème maculaire
- German Title of Invention:
- Behandlung von neovaskulären Augenerkrankungen, wie z.B. Maculadegeneration, angioiden Streifen, Uveitis und Makulaödemen
- SPC Number:
Dates
- Filing date:
- 29/11/2006
- Grant date:
- 22/08/2012
- EP Publication Date:
- 22/08/2012
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/06/2011
- EP B1 Publication Date:
- 22/08/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 29/11/2012
- Expiration date:
- 29/11/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/11/2006
- Name:
- GlaxoSmithKline LLC
- Address:
- One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, United States (US)
Inventor
1
- Name:
- Brigandi Richard Anthony
- Address:
- United States (US)
2
- Name:
- Miller William Henry
- Address:
- United States (US)
3
- Name:
- Levick Mark
- Address:
- United States (US)
Priority
- Priority Number:
- 740478 P
- Priority Date:
- 29/11/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/506;
| Filing date | Document type | Number of pages |
|---|